BRD4 Inhibitor Extends Survival in Mouse Model (IMAGE)
Caption
In an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors featuring fused proteins survived longer when treated with BRD4 inhibitors.
Credit
Cincinnati Children's
Usage Restrictions
none
License
Original content